Clarke D W, Brien J F, Nakatsu K, Taub H, Racz W J, Marks G S
Can J Physiol Pharmacol. 1983 Oct;61(10):1093-100. doi: 10.1139/y83-164.
A gas-liquid chromatographic assay using electron-capture detection was developed for the quantitation of 3,3',4,4'-tetrachlorobiphenyl (TCBP) in the serum, urine, brain, liver, adipose tissue, and feces of the rat. The sample preparation involves extraction of 3,3',4,4'-TCBP with hexane under neutral or alkaline conditions (and washing with concentrated acid for feces only). Aqueous standards are used for calibration of the assay, except for adipose tissue. The lower limit of quantitative sensitivity of the assay for 3,3',4,4'-TCBP is 25 ng/mL for serum and urine and 125 ng/g for brain, liver, adipose tissue, and feces, which can be extended to 5 ng/mL and 25 ng/g, respectively, by analyzing a larger aliquot of the hexane extract. The overall accuracy is greater than 95% for serum, urine, brain and feces and 86% for liver, and the within-day coefficient of variation does not exceed 8.6%. 3,3',4,4'-TCBP was administered orally to adult, female, Sprague-Dawley rats in the dosage regimens: 0.2, 0.5 and 2 mg X kg-1 X day-1 for 10 days and 5 mg X kg-1 X day-1 for 4 days. 3,3',4,4'-TCBP distributed preferentially into adipose tissue and liver, where the xenobiotic concentration was greater in adipose tissue. The adipose tissue and hepatic 3,3',4,4'-TCBP concentrations were dependent on both the absolute dose and dosing schedule of the xenobiotic. Only trace concentrations, usually below the lower limit of quantitation, were detected in the serum, brain and kidney. Fecal excretion of 3,3',4,4'-TCBP was greater than urinary excretion for the 5 mg X kg-1 X day-1 X 4-day regimen.
建立了一种使用电子捕获检测的气液色谱分析法,用于定量大鼠血清、尿液、脑、肝、脂肪组织和粪便中的3,3',4,4'-四氯联苯(TCBP)。样品制备包括在中性或碱性条件下用己烷萃取3,3',4,4'-TCBP(仅粪便需用浓酸洗)。除脂肪组织外,使用水溶液标准品对该分析进行校准。该分析对3,3',4,4'-TCBP的定量灵敏度下限为血清和尿液25 ng/mL,脑、肝、脂肪组织和粪便125 ng/g,通过分析更大体积的己烷提取物,下限可分别扩展至5 ng/mL和25 ng/g。血清、尿液、脑和粪便的总体准确度大于95%,肝脏为86%,日内变异系数不超过8.6%。以0.2、0.5和2 mg·kg-1·天-1的剂量方案给成年雌性Sprague-Dawley大鼠口服3,3',4,4'-TCBP,持续10天,以及5 mg·kg-1·天-1的剂量方案持续4天。3,3',4,4'-TCBP优先分布于脂肪组织和肝脏,其中该外源化合物在脂肪组织中的浓度更高。脂肪组织和肝脏中3,3',4,4'-TCBP的浓度取决于外源化合物的绝对剂量和给药方案。在血清、脑和肾中仅检测到痕量浓度,通常低于定量下限。对于5 mg·kg-1·天-1×4天的给药方案,3,3',4,4'-TCBP的粪便排泄量大于尿液排泄量。